Composition

US6653298B2 · kind B2 · utility

Assignees

• Sterix Limited · GB
• SCHERING CORPORATION · US

Inventors

• Barry Victor Lloyd Potter · Slough, GB
• Michael John Reed · London, GB
• Walter Elger · Berlin, DE
• Gudrun Roddersen · Jena, DE
• Heinrich-Thomas Proske · Berlin, DE

Key dates

• Filing date: Jan 5, 2001
• Grant date: Nov 25, 2003
• Expiry date: Jan 5, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/567
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed and claimed are methods for oral contraception, or a hormone replacement therapy, or for treating breast cancer, in a patient in need thereof involving administering to the patient, at a dosage of no greater than 200 &mgr;g/day per 70 kg subject, a compound having Formula (I): wherein X in combination with K form a steroidal ring and R5 is a sulphamate group that has of the formula: wherein each of R1 and R2 is H.